Ryan Langston
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
11
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Buy | $283 → $275 | $208.83 | +31.69% | 2 | Oct 28, 2024 | |
| ELV Elevance Health | Maintains: Buy | $589 → $484 | $417.86 | +15.83% | 2 | Oct 21, 2024 | |
| ASTH Astrana Health | Initiates: Buy | $66 | $54.30 | +21.55% | 1 | Oct 14, 2024 | |
| ADUS Addus HomeCare | Maintains: Buy | $128 → $137 | $128.96 | +6.23% | 4 | Aug 8, 2024 | |
| EHAB Enhabit | Maintains: Market Perform | $12 → $11 | $7.63 | +44.17% | 2 | Mar 11, 2024 |
Universal Health Services
Oct 28, 2024
Maintains: Buy
Price Target: $283 → $275
Current: $208.83
Upside: +31.69%
Elevance Health
Oct 21, 2024
Maintains: Buy
Price Target: $589 → $484
Current: $417.86
Upside: +15.83%
Astrana Health
Oct 14, 2024
Initiates: Buy
Price Target: $66
Current: $54.30
Upside: +21.55%
Addus HomeCare
Aug 8, 2024
Maintains: Buy
Price Target: $128 → $137
Current: $128.96
Upside: +6.23%
Enhabit
Mar 11, 2024
Maintains: Market Perform
Price Target: $12 → $11
Current: $7.63
Upside: +44.17%